ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT AGAINST MRSA (Multi-drug Resistant Staphylococcus Aureus)

Staphylococcus aureus are commonly associated with the nasal mucosa and the most common cause of hospital-acquired infections. This bacterium is responsible for 40-50% of surgical wound infections, and a range of other problems ranging from superficial cutaneous infections to serious infections such a pneumonia, septicaemia, osteomyelitis and endocarditis. Toxins of staphylococcal origin can cause toxic shock syndrome, skin desquamation and gastroenteritis.
 
The increasing emergence of resistance in S Aureus to commonly used antibiotics (including penicillin and methicillin) is of increasing concern in hospitals internationally where it is critical to eliminate MRSA from the patients' external environment.
 
VIRUCIDE-100 Hospital Disinfectant passes at a dilution of 1:200 when tested against MRSA in accordance with European Standard EN1276 (dilution in hard water, 5 min contact time, 200C, dirty conditions (3.0g/l bovine albumin).

ANTI-VIRAL ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT

HIV (Human Immunodeficiency Virus) and Hepatitis are the main viruses of concern in healthcare and related areas where frequent contact with blood and other body fluids can present a substantial infection risk. Inspite of its highly infectious nature, the HIV/AIDS virus has a limited survival times on inanimate objects and is easily inactivated by routine disinfection procedures. Hepatitis on the other hand, can be more persistent in the Healthcare work environment, and can survive relatively well on contaminated surfaces and hands, hence retaining their ability to cause infection.
 
VIRUCIDE-100 Hospital Disinfectant tested against Hepatitis B passed at the recommended use dilution of 1:100.

ANTI-FUNGAL ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT

VIRUCIDE-100 Hospital Disinfectant passes European Standard EN1657 test for anti-fungal activity at a dilution of 1:200 (v/v) against the test organisms Aspergillus niger and Candida albicans.
 
Not all yeasts and fungi are pathogenic in humans. However, fungal infections can be life threatening in patients who are immuno-compromised following viral infection (e.g. HIV), or as a result of being administered immuno-suppressive drugs to prevent organ rejection following transplants.
 
Yeast infections such as Thrush caused by Candida albicans, can be acquired endogenously as yeasts are part of the normal flora of the intestinal tract, vagina and mouth.
 
Aspergillus is a saprophytic fungus commonly found associated with dust and soil. It can pose a threat particularly to organ transplant patients, cystic fibrosis patients with a weakened pulmonary system. Another fungal organism that can cause severe pneumonia in immunocompromised patients is Pneumocystis carinii, originally thought to be a protozoan.
 
Dermatophytic fungi are responsible for causing superficial infections of the skin, hair, and nails such as athletes foot, ringworm infections and are readily transmitted through person-to-person contact in hospital bathrooms and recreational areas.

ANTI-TUBERCULOCIDAL ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT

VIRUCIDE-100 Hospital Disinfectant was found to possesses Tuberculocidal activity when tested in according to European Standard EN14204 at a dilution of 1:200 against the model organism Mycobacterium terrae.
 
Mycobacteria are a diverse family of Gram-positive, acid-fast bacilli found in animals, birds, soil and water. They are responsible for some of the most devastating human infectious diseases such as tuberculosis (M. tuberculosis) and leprosy (M. lepra). Tuberculosis is closely linked with poverty and is on the increase in areas with a high prevalence of immunosuppressive disorders such as HIV. The increasing hospitalisation of AIDS patients and the fact that tuberculosis can be spread by casual contact means that the disease has now assumed nosocomial importance.
 
Although air-borne infective droplets are the predominant mode of transmission, contaminated hospital equipment (endoscopes, respiratory masks, etc.) is a concern. The ability of Mycobacteria to survive unusually long periods under quite hostile physical conditions (heat, desiccation), and to exhibit high resistance to chemical agents (drugs, disinfectants), is attributed to their protective waxy cell walls.

ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT AGAINST GASTRO-INTESTINAL INFECTIONS

VIRUCIDE-100 Hospital Disinfectant passes European Standard EN1276 when tested at a dilution of 1:200 (v/v) against the test organisms Shigella sonnei and Salmonella typhimurium with 5 min contact time. Testing was carried out at 200C under dirty conditions (3.0g/l bovine albumin) for the reference strain indicated.
 
Shigellosis and Salmonellosis are both infections of the gastro-intestinal tract causing severe illness involving diarrhea, fever, and stomach cramps. Transmission is predominantly through the oral-faecal route, and occurs commonly as a result of poor hand hygiene in the healthcare sector and the ingestion of contaminated food.

ACTIVITY OF VIRUCIDE-100 HOSPITAL DISINFECTANT AGAINST LISTERIA

VIRUCIDE-100 Hospital Disinfectant was found to be effective against Listeria monocytogenes when tested in accordance with European Standard EN1276 at a dilution of 1:200 (v/v) within 5 min contact time. Testing was carried out at 200C under hard water and dirty conditions (3.0g/l bovine albumin) for the reference strain indicated.
 
Listeriosis is a serious bacterial infection caused by ingestion of Listeria monocytogenes, typically found in manure contaminated soil or water, which can result in contamination of food through irrigation. Animals can act as carriers of the bacterium without appearing to be ill, and can resulting in contamination of food of animal origin, such as meat and dairy products.
 
Pregnant women, newborns, and adults with weak immune systems are particularly susceptible to infection and exposure to Listeria monocytogenes in the hospital environment should be prevented. Symptoms are typically gastro-intestinal, but can include headache, stiff neck, confusion, loss of balance and convulsions should the infection subsequently spread to the nervous system.